Menu
GeneBe

rs1800266

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004006.3(DMD):c.1095A>C(p.Gln365His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000502 in 1,209,990 control chromosomes in the GnomAD database, including 3 homozygotes. There are 223 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q365R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., 11 hem., cov: 23)
Exomes 𝑓: 0.00052 ( 3 hom. 212 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

1
5
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:9

Conservation

PhyloP100: 2.14
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03573519).
BP6
Variant X-32645018-T-G is Benign according to our data. Variant chrX-32645018-T-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 282487.We mark this variant Likely_benign, oryginal submissions are: {Benign=6, Likely_benign=1, Uncertain_significance=1}. Variant chrX-32645018-T-G is described in Lovd as [Benign]. Variant chrX-32645018-T-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.000519 (570/1098142) while in subpopulation MID AF= 0.00604 (25/4137). AF 95% confidence interval is 0.0042. There are 3 homozygotes in gnomad4_exome. There are 212 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd at 11 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DMDNM_004006.3 linkuse as main transcriptc.1095A>C p.Gln365His missense_variant 10/79 ENST00000357033.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DMDENST00000357033.9 linkuse as main transcriptc.1095A>C p.Gln365His missense_variant 10/791 NM_004006.3 P4

Frequencies

GnomAD3 genomes
AF:
0.000340
AC:
38
AN:
111848
Hom.:
0
Cov.:
23
AF XY:
0.000323
AC XY:
11
AN XY:
34008
show subpopulations
Gnomad AFR
AF:
0.0000975
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000956
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000620
Gnomad OTH
AF:
0.000664
GnomAD3 exomes
AF:
0.000529
AC:
97
AN:
183391
Hom.:
0
AF XY:
0.000693
AC XY:
47
AN XY:
67849
show subpopulations
Gnomad AFR exome
AF:
0.000304
Gnomad AMR exome
AF:
0.0000729
Gnomad ASJ exome
AF:
0.000267
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00152
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000647
Gnomad OTH exome
AF:
0.00155
GnomAD4 exome
AF:
0.000519
AC:
570
AN:
1098142
Hom.:
3
Cov.:
31
AF XY:
0.000583
AC XY:
212
AN XY:
363538
show subpopulations
Gnomad4 AFR exome
AF:
0.0000379
Gnomad4 AMR exome
AF:
0.0000568
Gnomad4 ASJ exome
AF:
0.000103
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00194
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000477
Gnomad4 OTH exome
AF:
0.000716
GnomAD4 genome
AF:
0.000340
AC:
38
AN:
111848
Hom.:
0
Cov.:
23
AF XY:
0.000323
AC XY:
11
AN XY:
34008
show subpopulations
Gnomad4 AFR
AF:
0.0000975
Gnomad4 AMR
AF:
0.0000956
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000620
Gnomad4 OTH
AF:
0.000664
Alfa
AF:
0.000615
Hom.:
25
Bravo
AF:
0.000416
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
3
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.000892
AC:
6
ExAC
AF:
0.000642
AC:
78
EpiCase
AF:
0.00125
EpiControl
AF:
0.000948

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 07, 2015- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJun 25, 2020Variant summary: DMD c.1095A>C (p.Gln365His) results in a non-conservative amino acid change in the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00053 in 183391 control chromosomes, predominantly at a frequency of 0.0015 within the South Asian subpopulation in the gnomAD database. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 136 fold of the estimated maximal expected allele frequency for a pathogenic variant in DMD causing Dystrophinopathies phenotype strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. c.1095A>C has been reported in the literature as a benign sequence variant in a cohort of patients enrolled in the United Dystrophinopathy Project, a multicenter research consortium, and in referral samples submitted for mutation analysis with a diagnosis of dystrophinopathy (Flanigan_2009). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (benign/likely benign, n=5). Based on the evidence outlined above, the variant was classified as benign. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 18, 2019The p.Gln365His variant in DMD is classified as benign because it has been ident ified in 0.15% (29/19076) of South Asian chromosomes including 16 hemizygotes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP criteria applied: BA1. -
not provided Benign:3
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 25, 2021This variant is associated with the following publications: (PMID: 7849724, 24274981, 19937601) -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Duchenne muscular dystrophy Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMay 18, 2021- -
Benign, criteria provided, single submitterclinical testingInvitaeJan 29, 2024- -
Dilated cardiomyopathy 3B Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 20, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.54
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.24
Cadd
Benign
21
Dann
Uncertain
0.99
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.86
D;.;D;D;D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.036
T;T;T;T;T
MetaSVM
Benign
-0.67
T
MutationTaster
Benign
0.89
D;D;D
PrimateAI
Uncertain
0.55
T
Sift4G
Pathogenic
0.0010
D;D;D;D;D
Polyphen
1.0
.;D;.;.;D
Vest4
0.43
MutPred
0.55
.;.;Loss of stability (P = 0.1213);Loss of stability (P = 0.1213);.;
MVP
0.76
MPC
0.075
ClinPred
0.055
T
GERP RS
0.44
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1800266; hg19: chrX-32663135; COSMIC: COSV55891577; COSMIC: COSV55891577; API